When the Body Attacks the Mind: Biology and Madness

By |2016-07-12T03:40:20-07:00July 12th, 2016|We Know Psychiatry|

Writing in the JULY/AUGUST 2016 ISSUE of The Atlantic, Moises Velasquez-Manoff describes a 13-year-old boy named Sasha who was admitted to a hospital with what could only be described as complete madness. Until a clever neurologist put two and two together and determined that the boy's delusional behavior was an [...]

Efficacy and Safety of Basimglurant as Adjunctive Therapy for Major Depression: A Randomized Clinical Trial

By |2016-07-07T16:09:51-07:00July 7th, 2016|We Know Psychiatry|

Efficacy and Safety of Basimglurant as Adjunctive Therapy for Major Depression: A Randomized Clinical Trial Jorge A. Quiroz, MD, MBA; Paul Tamburri, PharmD; Dennis Deptula, PhD; Ludger Banken, PhD; Ulrich Beyer, PhD; Michael Rabbia, MA; Nikhat Parkar, MSc; Paulo Fontoura, MD, PhD; Luca Santarelli, MD ABSTRACT Importance  Antagonism of the postsynaptic metabotropic glutamate subtype 5 receptor is a novel approach to modulate glutamatergic function and has proven efficacy in [...]

ASSOCIATIONS BETWEEN CANNABIS & TOBACCO USE IN EARLY MIDLIFE: UPDATE

By |2016-06-08T15:53:54-07:00June 8th, 2016|We Know Psychiatry|

  After major policy changes in the United States, policymakers, health care professionals, and the general public seek information about whether recreational cannabis use is associated with physical health problems later in life, as compared with numerous known risks of tobacco use. Participants belonged to a representative birth cohort of [...]

Associations Between Cannabis & Tobacco Use in Early Midlife: Bad News for Dentists

By |2016-06-04T23:01:55-07:00June 4th, 2016|We Know Psychiatry|

A Longitudinal Comparison of Persistent Cannabis vs Tobacco Users Marijuana users might glean some good news from a soon to be published report comparing Cannabis vs. tobacco users, except when it comes to their dentists. After major policy changes in the United States, policymakers, health care professionals, and the general [...]

Call For Papers — 2016/2017; New Section on Epigenetics Introduced

By |2016-06-03T13:04:46-07:00June 3rd, 2016|We Know Psychiatry|

  Medworks Media - 2016 MEDWORKS MEDIA June 3, 2016 Los Angeles CA www.medworksmedia.com Psychopharmacology Bulletin DIGITAL ISSN: 2472-2448; PRINT ISSN: 0048-5764   Call For Papers — 2016/2017 New Section on Epigenetics Introduced   From: Michael E. Thase, MD, Editor-in-Chief James La Rossa Jr., Editorial Director This is a general [...]

New Evidence Suggests that Children with ADHD and Autistic Spectrum Disorder may have lower Omega-3 and Omega-6 Polyunsaturated Fatty Acid Levels

By |2016-05-31T13:36:02-07:00May 31st, 2016|We Know Psychiatry|

By Natalie Parletta, Theophile Niyonsenga, and Jacques Duff Abstract Background There is evidence that children with Attention Deficit Hyperactivity Disorder (ADHD) and Autistic Spectrum Disorder (ASD) have lower omega-3 polyunsaturated fatty acid (n-3 PUFA) levels compared with controls and conflicting evidence regarding omega-6 (n-6) PUFA levels. Objectives This study investigated whether erythrocyte [...]

Attention-Deficit/Hyperactivity Disorder Trajectories From Childhood to Young Adulthood: Evidence From a Birth Cohort Supporting a Late-onset Syndrome

By |2016-05-31T13:16:56-07:00May 31st, 2016|We Know Psychiatry|

By Arthur Caye; Thiago Botter-Maio Rocha, MD, MSc; Luciana Anselmi, PhD; Joseph Murray, PhD; Ana M. B. Menezes, PhD; Fernando C. Barros, PhD; Helen Gonçalves, PhD; Fernando Wehrmeister, PhD; Christina M. Jensen, MSc; Hans-Christoph Steinhausen, MD, PhD, DMSc; James M. Swanson, PhD; Christian Kieling, MD, PhD; Luis Augusto Rohde, MD, PhD ABSTRACT Importance  The requirement of a childhood onset has always been a key criterion for the diagnosis of attention-deficit/hyperactivity disorder (ADHD) in adults, but [...]

Go to Top